Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron H N van Schaik

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Investigational New Drugs|November 4, 2005
Cancer treatment and pharmacogenetics of cytochrome P450 enzymesRon H N van Schaik
Therapeutic Drug Monitoring|July 2, 2004
Implications of cytochrome P450 genetic polymorphisms on the toxicity of antitumor agentsRon H N van Schaik
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 20, 2008
CYP450 pharmacogenetics for personalizing cancer therapyRon H N van Schaik
European Journal of Cancer (Oxford, England : 1990)|December 6, 2005
Genotyping and phenotyping cytochrome P450: perspectives for cancer treatmentRon H J Mathijssen, Ron H N van Schaik
Current Pharmaceutical Design|March 11, 2010
Genetic techniques for pharmacogenetic analysesTahar van der Straaten, Ron H N van Schaik
Drug Metabolism and Personalized Therapy|February 9, 2018
Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCRKirsten M Pondman, Ron H N van Schaik, Jan van der Weide
Frontiers in Pharmacology|October 12, 2020
Pharmacogenetics in Psychiatry: An Update on Clinical UsabilityRon H N van Schaik, Daniel J Müller, Alessandro Serretti, et al.
Molecular Diagnosis & Therapy|November 30, 2012
Pharmacogenetics in kidney transplantation: recent updates and potential clinical applicationsLaure Elens, Dennis A Hesselink, Ron H N van Schaik, et al.
Pharmacogenomics|June 4, 2008
A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporineDennis A Hesselink, Ron H N van Schaik, Jeroen Nauta, et al.
Clinical Chemistry|June 23, 2017
Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical PracticeMaja Matic, Saskia N de Wildt, Dick Tibboel, et al.
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Investigational New Drugs|November 4, 2005
Cancer treatment and pharmacogenetics of cytochrome P450 enzymesRon H N van Schaik
Therapeutic Drug Monitoring|July 2, 2004
Implications of cytochrome P450 genetic polymorphisms on the toxicity of antitumor agentsRon H N van Schaik
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 20, 2008
CYP450 pharmacogenetics for personalizing cancer therapyRon H N van Schaik
European Journal of Cancer (Oxford, England : 1990)|December 6, 2005
Genotyping and phenotyping cytochrome P450: perspectives for cancer treatmentRon H J Mathijssen, Ron H N van Schaik
Current Pharmaceutical Design|March 11, 2010
Genetic techniques for pharmacogenetic analysesTahar van der Straaten, Ron H N van Schaik
Drug Metabolism and Personalized Therapy|February 9, 2018
Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCRKirsten M Pondman, Ron H N van Schaik, Jan van der Weide
Frontiers in Pharmacology|October 12, 2020
Pharmacogenetics in Psychiatry: An Update on Clinical UsabilityRon H N van Schaik, Daniel J Müller, Alessandro Serretti, et al.
Molecular Diagnosis & Therapy|November 30, 2012
Pharmacogenetics in kidney transplantation: recent updates and potential clinical applicationsLaure Elens, Dennis A Hesselink, Ron H N van Schaik, et al.
Pharmacogenomics|June 4, 2008
A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporineDennis A Hesselink, Ron H N van Schaik, Jeroen Nauta, et al.
Clinical Chemistry|June 23, 2017
Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical PracticeMaja Matic, Saskia N de Wildt, Dick Tibboel, et al.
Pageof 27